AG
NKTR icon

AmeriFlex Group’s Nektar Therapeutics NKTR Stock Holding History

AmeriFlex Group’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$908 Hold
13
– – ﹤0.01% 1431
2026
Q1 		$935 Hold
13
– – ﹤0.01% 998
2025
Q4 		$550 Sell
13
-13
-50% -$728 ﹤0.01% 1052
2025
Q3 		$1.48K Buy
26
+13
+100% +$430 ﹤0.01% 988
2025
Q2 		$386 Hold
13
– – ﹤0.01% 1029
2025
Q1 		$136 Hold
13
– – ﹤0.01% 1255
2024
Q4 		$165 Buy
+13
New +$229 ﹤0.01% 1142

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AmeriFlex Group's NKTR Position: Q2 2026 in Review

AmeriFlex Group held its Nektar Therapeutics (NKTR) position steady in Q2 2026 at 13 shares worth $908. The position accounts for ﹤0.01% of the portfolio, ranked #1431.

AmeriFlex Group first reported a position in NKTR in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.48K in Q3 2025. 240 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • AmeriFlex Group held 13 shares of Nektar Therapeutics worth $908 as of Q2 2026.
  • AmeriFlex Group left its Nektar Therapeutics share count unchanged in Q2 2026.
  • Nektar Therapeutics made up ﹤0.01% of AmeriFlex Group's portfolio in Q2 2026, its #1431 holding.
  • AmeriFlex Group first reported a position in Nektar Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • AmeriFlex Group's Nektar Therapeutics position peaked at $1.48K in Q3 2025.
  • 240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.